Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 434

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Multiagent Chemotherapy and Deferred Radiotherapy in Infants With Malignant Brain Tumors: A Report From the Children’s Cancer Group

Geyer, J. Russell, Sposto, Richard, Jennings, Mark, Boyett, James M., Axtell, Richard A., Breiger, David, Broxson, Emmett, Donahue, Bernadine, Finlay, Jonathan L., Goldwein, Joel W., Heier, Linda A., Johnson, Dennis, Mazewski, Claire, Miller, Douglas C., Packer, Roger, Puccetti, Diane, Radcliffe, Jerilynn, Tao, May Lin, Shiminski-Maher, Tania·2005·Journal of Clinical Oncology

Abstract

Purpose: To evaluate response rate, event-free survival (EFS), and toxicity of two chemotherapeutic regimens for treatment of children younger than 36 months with malignant brain tumors and to estimate control intervals without irradiation in children with no residual tumor after initial surgery and induction chemotherapy and with delayed irradiation in patients with residual tumor or metastatic disease at diagnosis. Patients and Methods: Patients were randomly assigned to one of two regimens of induction chemotherapy (vincristine, cisplatin, cyclophosphamide, and etoposide v vincristine, carboplatin, ifosfamide, and etoposide). Maintenance chemotherapy began after induction in children without progressive disease. Children with no residual tumors after induction therapy and no metastatic disease at diagnosis were not to receive radiation therapy unless their tumors progressed. Results: Two hundred ninety-nine infants were enrolled. Forty-two percent of patients responded to induction chemotherapy. At 5 years from study entry, the EFS rate was 27% ± 3%, and the survival rate was 43% ± 3%. There was no significant difference between the two arms in terms of response rate or EFS. For medulloblastoma, supratentorial primitive neuroectodermal tumor, ependymoma, and rhabdoid tumors, 5-year EFS rates were 32% ± 5%, 17% ± 6%, and 32% ± 6%, and 14% ± 7%, respectively. Fifty-eight percent of patients who were alive 5 years after study entry had not received radiation therapy. Conclusion: Intensified induction chemotherapy resulted in a high response rate of malignant brain tumors in infants. Survival was comparable to that of previous studies, and most patients who survived did not receive radiation therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2005.09.095

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 434

Metadata

Authors
Geyer, J. R., Sposto, R., Jennings, M., Boyett, J. M., Axtell, R. A., Breiger, D., Broxson, E., Donahue, B., Finlay, J. L., Goldwein, J. W., Heier, L. A., Johnson, D., Mazewski, C., Miller, D. C., Packer, R., Puccetti, D., Radcliffe, J., Tao, M. L., & Shiminski-Maher, T.
Venue
Journal of Clinical Oncology
Published
2005-10-20
Volume
23
Issue
30
Pages
7621-7631
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2160619817
Cited by
434
References
11
FWCI
6.95
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiagent Chemotherapy and Deferred Radiotherapy in Infants With Malignant Brain Tumors: A Report From the Children’s Cancer Group. https://app.cochat.ai/papers/10.1200/jco.2005.09.095
The paper
Geyer, J. R., Sposto, R., Jennings, M., Boyett, J. M., Axtell, R. A., Breiger, D., Broxson, E., Donahue, B., Finlay, J. L., Goldwein, J. W., Heier, L. A., Johnson, D., Mazewski, C., Miller, D. C., Packer, R., Puccetti, D., Radcliffe, J., Tao, M. L., & Shiminski-Maher, T. (2005). Multiagent Chemotherapy and Deferred Radiotherapy in Infants With Malignant Brain Tumors: A Report From the Children’s Cancer Group. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2005.09.095

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.